Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-24-008168
Filing Date
2024-01-30
Accepted
2024-01-30 15:16:56
Documents
63

Document Format Files

Seq Description Document Type Size
1 FORM F-1/A tm2334005-3_f1a.htm F-1/A 5705486
2 EXHIBIT 4.4 tm2334005d4_ex4-4.htm EX-4.4 110668
3 EXHIBIT 4.5 tm2334005d4_ex4-5.htm EX-4.5 110451
4 EXHIBIT 4.6 tm2334005d4_ex4-6.htm EX-4.6 113031
5 EXHIBIT 5.1 tm2334005d4_ex5-1.htm EX-5.1 35803
6 EXHIBIT 8.2 tm2334005d4_ex8-2.htm EX-8.2 19722
7 EXHIBIT 10.1 tm2334005d4_ex10-1.htm EX-10.1 233402
8 EXHIBIT 23.1 tm2334005d4_ex23-1.htm EX-23.1 2649
9 EX-FILING FEES tm2334005d4_ex-filingfees.htm EX-FILING FEES 60025
10 GRAPHIC bc_fig13pioneer-4c.jpg GRAPHIC 30201
11 GRAPHIC bc_fig16stage-4c.jpg GRAPHIC 30594
12 GRAPHIC bc_fig19lesions-4c.jpg GRAPHIC 41911
13 GRAPHIC bc_fig43kidneys-4c.jpg GRAPHIC 25167
14 GRAPHIC bc_fig47immunization-4c.jpg GRAPHIC 26783
15 GRAPHIC bc_fig48splenocytes-4c.jpg GRAPHIC 35423
16 GRAPHIC bc_fig49akilling-4c.jpg GRAPHIC 76748
17 GRAPHIC bc_fig49killing-4c.jpg GRAPHIC 38699
18 GRAPHIC bc_fig51tcellresponse-4c.jpg GRAPHIC 43939
19 GRAPHIC bc_fig52antibody-4c.jpg GRAPHIC 22079
20 GRAPHIC fc_fig03aiimmunolonew-4clr.jpg GRAPHIC 99521
21 GRAPHIC fc_fig05stagedevelop-4c.jpg GRAPHIC 45718
22 GRAPHIC fc_fig06ourstarat-4c.jpg GRAPHIC 112297
23 GRAPHIC fc_fig12cancer-4c.jpg GRAPHIC 43857
24 GRAPHIC fc_fig15pioneer-4c.jpg GRAPHIC 42345
25 GRAPHIC fc_fig17vaccine-4clr.jpg GRAPHIC 82873
26 GRAPHIC fc_fig24pembrolizumab-4c.jpg GRAPHIC 21785
27 GRAPHIC fc_fig36discovery-4c.jpg GRAPHIC 127689
28 GRAPHIC fc_fig38eden-4clr.jpg GRAPHIC 115130
29 GRAPHIC fc_fig39vaccine-4c.jpg GRAPHIC 56940
30 GRAPHIC fc_fig44glase-4c.jpg GRAPHIC 119623
31 GRAPHIC fc_fig50panproteome-4c.jpg GRAPHIC 82816
32 GRAPHIC lc_fig14tumorvolum-4c.jpg GRAPHIC 78226
33 GRAPHIC lc_fig20prepost-bw.jpg GRAPHIC 55776
34 GRAPHIC lc_fig21prepostfollow-bw.jpg GRAPHIC 44542
35 GRAPHIC lc_fig22mannwhitney-bw.jpg GRAPHIC 42349
36 GRAPHIC lc_fig23neoantigen-4c.jpg GRAPHIC 70709
37 GRAPHIC lc_fig27tumor-4c.jpg GRAPHIC 38500
38 GRAPHIC lc_fig28isotype-4c.jpg GRAPHIC 52750
39 GRAPHIC lc_fig29control-4c.jpg GRAPHIC 75360
40 GRAPHIC lc_fig30inoculation-4c.jpg GRAPHIC 69578
41 GRAPHIC lc_fig31backbone-4c.jpg GRAPHIC 49275
42 GRAPHIC lc_fig33clinical-bw.jpg GRAPHIC 96970
43 GRAPHIC lc_fig34liuhugovan-4c.jpg GRAPHIC 53554
44 GRAPHIC lc_fig37neisseria-bw.jpg GRAPHIC 142520
45 GRAPHIC lc_fig40evxb1-4c.jpg GRAPHIC 23812
46 GRAPHIC lc_fig41abcess-4c.jpg GRAPHIC 37370
47 GRAPHIC lc_fig42halfmax-4c.jpg GRAPHIC 21351
48 GRAPHIC lc_fig45evxb2-4c.jpg GRAPHIC 98294
49 GRAPHIC lc_fig46auclog-4c.jpg GRAPHIC 63204
50 GRAPHIC lg_evaxionaiimmunology-bwlr.jpg GRAPHIC 10969
51 GRAPHIC pc_fig04aiimmunolo-4c.jpg GRAPHIC 57315
52 GRAPHIC ph_fig25week-4c.jpg GRAPHIC 117538
53 GRAPHIC ph_fig26evx2evx3-4clr.jpg GRAPHIC 78952
54 GRAPHIC ph_fig35bacterial-4c.jpg GRAPHIC 56165
55 GRAPHIC tb_fig02milestones-4c.jpg GRAPHIC 67060
56 GRAPHIC tb_fig18tumor-4c.jpg GRAPHIC 76653
57 GRAPHIC tb_fig20trae-4clr.jpg GRAPHIC 21615
58 GRAPHIC tb_fig32inoculatnew-4clr.jpg GRAPHIC 45681
59 GRAPHIC tm233400d4_ex8-2img001.jpg GRAPHIC 2848
60 GRAPHIC tm233400d4_ex8-2img002.jpg GRAPHIC 1737
61 GRAPHIC tm2334005d4_ex5-1img001.jpg GRAPHIC 3160
62 GRAPHIC tm2334005d4_ex5-1img002.jpg GRAPHIC 798
63 GRAPHIC tm2334005d4_ex5-1img003.jpg GRAPHIC 1887
  Complete submission text file 0001104659-24-008168.txt   10406715
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-276505 | Film No.: 24577750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)